ESR1 and breast cancer: The ER+ patients were treated by hormone therapy after they were diagnosed as breast cancer and performed surgery resection, whereas a preferred drug of hormone therapy is Tam (tamoxifen), which is an antagonist of the estrogen receptor in breast tissue and has been widely used for the treatment for both early and advanced ER+ breast cancers in women [32].